discontinue sulfonylurea when starting glp-1 receptor agonist should I stop gliclazide (sulfonylurea) in a patient with controlled blood glucose levels on Ozempic (semaglutide), linagliptin (DPP-4 inhibitor), and metformin (biguanide)? A System-Based Review on Effects

Lancet Diabetes Endocrinol 3(5):367381 van Bommel EJM, Muskiet MHA, Tonneijck L, Kramer MHH, Nieuwdorp M, van Raalte DH (2017) SGLT2 inhibition in the diabetic kidneyfrom mechanisms to clinical outcome

GLP-1 medications may also complicate various health conditions

Evaluation of the risk of bias

Clinical trial criteria excluded a significant number of adults without diabetes eligible for GLP-1 receptor agonist treatment from studies assessing the drugs safety and efficacy, results of a research letter showed

Additionally, innovative formulations and administration methods, such as once-weekly injections and oral options, enhance patient convenience and adherence

Achieving body weight loss of 515% can improve cardiometabolic parameters including prediabetes, dyslipidemia, and hypertension [5, 9]